Goldman Sachs Group (the) Stock News

Walgreens Boots Alliance (WBA) is reportedly in talks with Goldman Sachs to discuss the potential disposal of the UK chemist chain in a deal valued at well over £5bn, according to Sky News. City sources told Sky that the chains value could be between £10bn and £12bn, adding that it was unclear whether any emerging

Goldman Sachs Group Inc. reduced its stake in Chimerix, Inc. (NASDAQ:CMRX) by 87.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 81,344 shares of the biopharmaceutical companys stock after selling 581,493 shares during the period. Goldman Sachs Group Inc. owned approximately []

Goldman Sachs Group Inc. lowered its stake in shares of Luther Burbank Co. (NASDAQ:LBC) by 20.1% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,858 shares of the companys stock after selling 13,509 shares during the quarter. Goldman Sachs Group Inc. owned approximately []

Goldman Sachs Group Inc. increased its position in shares of The ExOne Company (NASDAQ:XONE) by 109.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,770 shares of the industrial products companys stock after purchasing an additional 13,492 []

Joel Isaacson & Co. LLC increased its position in shares of The Goldman Sachs Group, Inc. (NYSE:GS) by 1.5% during the third quarter, Holdings Channel reports. The fund owned 9,506 shares of the investment management companys stock after acquiring an additional 142 shares during the quarter. Joel Isaacson & Co. LLCs holdings in The Goldman []

China''s goal of net-zero carbon emissions by 2060 could generate $16 trillion in infrastructure investment opportunities.

AJ Wealth Strategies LLC boosted its stake in shares of The Goldman Sachs Group, Inc. (NYSE:GS) by 15.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,412 shares of the investment management companys stock after acquiring an additional 186 shares during []

Stratos Wealth Advisors LLC reduced its stake in Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF (NYSEARCA:GSLC) by 43.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,542 shares of the companys stock after selling 4,286 shares during the period. []

Millennium Management LLC bought a new stake in Agile Therapeutics, Inc. (NASDAQ:AGRX) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 1,504,056 shares of the specialty pharmaceutical companys stock, valued at approximately $2,000,000. A number of other large investors have also recently modified their holdings of AGRX. Goldman Sachs Group Inc. raised its holdings []

Goldman Sachs Group Inc. boosted its stake in KludeIn I Acquisition Corp. (NASDAQ:INKA) by 20.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 69,470 shares of the companys stock after purchasing an additional 11,704 shares during the period. Goldman Sachs Group Inc. []

Goldman Sachs Group Inc. lifted its position in FutureFuel Corp. (NYSE:FF) by 41.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 69,689 shares of the energy companys stock after purchasing an additional 20,578 shares during the period. Goldman Sachs []

Goldman Sachs Group Inc. lowered its position in shares of Dorchester Minerals, L.P. (NASDAQ:DMLP) by 13.7% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 39,441 shares of the energy companys stock after selling 6,281 shares during the quarter. Goldman Sachs Group Inc. owned about 0.11% of []

Goldman Sachs Group Inc. raised its holdings in shares of VBI Vaccines Inc. (NASDAQ:VBIV) by 21.9% during the second quarter, according to its most recent filing with the SEC. The firm owned 202,191 shares of the biopharmaceutical companys stock after purchasing an additional 36,385 shares during the period. Goldman Sachs Group Inc.s holdings in VBI []

Goldman Sachs Group Inc. reduced its position in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) by 42.1% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,610 shares of the specialty pharmaceutical companys stock after selling 22,989 shares during the period. Goldman Sachs []

Goldman Sachs Group Inc. grew its position in Direxion Daily FTSE China Bear 3X Shares (NYSEARCA:YANG) by 120.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,076 shares of the companys stock after purchasing an additional 28,503 shares during the period. Goldman []